AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
8,291.10
-126.10 (-1.50%)
At close: Aug 14, 2025

AstraZeneca Pharma India Company Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.

The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.

AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

AstraZeneca Pharma India Limited
Country India
Founded 1979
Industry Pharmaceutical Preparations
Employees 802
CEO Praveen Akkinepally

Contact Details

Address:
Manyata Embassy Business Park
Bengaluru, 560045
India
Phone 91 80 6774 8000
Website astrazeneca.in

Stock Details

Ticker Symbol 506820
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Praveen Akkinepally Chief Executive Officer
Bhavana Agrawal Chief Financial Officer